• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity.H3K4 去甲基化酶 KDM5B 调节癌细胞特性和表观遗传可塑性。
Oncogene. 2022 May;41(21):2958-2972. doi: 10.1038/s41388-022-02311-z. Epub 2022 Apr 19.
2
KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer.KDM5B 是干细胞、发育和癌症中 H3K4 甲基化组的主要调节因子。
Semin Cancer Biol. 2019 Aug;57:79-85. doi: 10.1016/j.semcancer.2018.11.001. Epub 2018 Nov 16.
3
KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation.在胚胎干细胞自我更新和分化过程中,KDM5B使启动子和增强子附近的H3K4发生甲基化。
Genome Biol. 2014 Feb 4;15(2):R32. doi: 10.1186/gb-2014-15-2-r32.
4
KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.KDM5B 通过去甲基化 H3K4 来招募 XRCC1 并促进化学抗性。
Int J Biol Sci. 2018 Jun 22;14(9):1122-1132. doi: 10.7150/ijbs.25881. eCollection 2018.
5
Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.组蛋白赖氨酸去甲基化酶 KDM5B 通过多种表观遗传作用维持慢性髓系白血病。
Exp Hematol. 2020 Feb;82:53-65. doi: 10.1016/j.exphem.2020.01.006. Epub 2020 Jan 30.
6
Contribution of H3K4 demethylase KDM5B to nucleosome organization in embryonic stem cells revealed by micrococcal nuclease sequencing.通过微球菌核酸酶测序揭示 H3K4 去甲基酶 KDM5B 对胚胎干细胞核小体组织的贡献。
Epigenetics Chromatin. 2019 Apr 2;12(1):20. doi: 10.1186/s13072-019-0266-9.
7
The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.组蛋白H3K4特异性去甲基化酶KDM5B通过不同的植物同源结构域(PHD)指与底物和产物结合。
Cell Rep. 2014 Jan 30;6(2):325-35. doi: 10.1016/j.celrep.2013.12.021. Epub 2014 Jan 9.
8
Histone demethylase lysine demethylase 5B in development and cancer.发育与癌症中的组蛋白去甲基化酶赖氨酸去甲基化酶5B
Oncotarget. 2017 Jan 31;8(5):8980-8991. doi: 10.18632/oncotarget.13858.
9
Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.组蛋白去甲基化酶 KDM5B 的磷酸化及其对三阴性乳腺癌表型的调控。
Sci Rep. 2019 Nov 27;9(1):17663. doi: 10.1038/s41598-019-54184-0.
10
Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway.赖氨酸去甲基化酶 5B 通过 Wnt/β-连环蛋白通路抑制 CC 趋化因子配体 14 促进结直肠癌的进展。
Life Sci. 2021 Jan 1;264:118726. doi: 10.1016/j.lfs.2020.118726. Epub 2020 Nov 5.

引用本文的文献

1
Virus-human chromatin interactions reorganise 3D genome and hijack KDM5B for promoting metastasis in nasopharyngeal carcinoma.病毒与人类染色质相互作用重塑三维基因组并劫持KDM5B以促进鼻咽癌转移。
Nat Commun. 2025 Aug 4;16(1):7149. doi: 10.1038/s41467-025-61597-1.
2
KDM5D histone demethylase mediates p38α inactivation via its enzymatic activity to inhibit cancer progression.KDM5D组蛋白去甲基化酶通过其酶活性介导p38α失活,从而抑制癌症进展。
Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2402022121. doi: 10.1073/pnas.2402022121. Epub 2024 Dec 5.
3
Can -GIcNAc Transferase (OGT) Complex Be Used as a Target for the Treatment of Hematological Malignancies?O-连接的N-乙酰葡糖胺转移酶(OGT)复合物能否用作血液系统恶性肿瘤的治疗靶点?
Pharmaceuticals (Basel). 2024 May 22;17(6):664. doi: 10.3390/ph17060664.
4
Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747.甲基转移酶样蛋白 14 通过降低 LINC02747 的表达来抑制非小细胞肺癌的生长和转移。
Cancer Sci. 2024 Sep;115(9):2931-2946. doi: 10.1111/cas.16254. Epub 2024 Jun 18.
5
Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts.不同癌症背景下黏着蛋白与 WNT 信号通路之间的合成致死性。
Cells. 2024 Mar 30;13(7):608. doi: 10.3390/cells13070608.
6
Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis.组蛋白赖氨酸去甲基化酶 KDM5B 通过 miR-140-3p/BCL2 轴促进人急性髓系白血病细胞的增殖并抑制其凋亡。
RNA. 2024 Mar 18;30(4):435-447. doi: 10.1261/rna.079865.123.
7
Decoding the universal human chromatin landscape through teratoma-based profiling.通过基于畸胎瘤的分析解码通用的人类染色质景观。
Nucleic Acids Res. 2024 Apr 24;52(7):3589-3606. doi: 10.1093/nar/gkae021.
8
Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?癌细胞可塑性、干细胞因子与治疗抵抗:它们如何关联?
Cancer Metastasis Rev. 2024 Mar;43(1):423-440. doi: 10.1007/s10555-023-10144-9. Epub 2023 Oct 5.
9
Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets.组蛋白的翻译后修饰:机制、生物学功能及治疗靶点。
MedComm (2020). 2023 May 20;4(3):e292. doi: 10.1002/mco2.292. eCollection 2023 Jun.
10
Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5.临近标记揭示了组蛋白去甲基酶 KDM5 的一个新的体内相互作用因子网络。
Epigenetics Chromatin. 2023 Feb 18;16(1):8. doi: 10.1186/s13072-023-00481-y.

本文引用的文献

1
Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains.整合泛癌症分析揭示了癌症类型和细胞特异性染色质结构域中的表观基因组变化。
Nat Commun. 2021 Mar 3;12(1):1419. doi: 10.1038/s41467-021-21707-1.
2
RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB.NCI-60 的 RNA 测序:整合到 CellMiner 和 CellMiner CDB 中。
Cancer Res. 2019 Jul 1;79(13):3514-3524. doi: 10.1158/0008-5472.CAN-18-2047. Epub 2019 May 21.
3
Spontaneously slow-cycling subpopulations of human cells originate from activation of stress-response pathways.人类细胞的自发缓慢循环亚群源自应激反应途径的激活。
PLoS Biol. 2019 Mar 13;17(3):e3000178. doi: 10.1371/journal.pbio.3000178. eCollection 2019 Mar.
4
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.KDM5 组蛋白去甲基化酶活性将细胞转录组异质性与治疗抵抗联系起来。
Cancer Cell. 2018 Dec 10;34(6):939-953.e9. doi: 10.1016/j.ccell.2018.10.014. Epub 2018 Nov 21.
5
KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer.KDM5B 是干细胞、发育和癌症中 H3K4 甲基化组的主要调节因子。
Semin Cancer Biol. 2019 Aug;57:79-85. doi: 10.1016/j.semcancer.2018.11.001. Epub 2018 Nov 16.
6
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
7
Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma.KDM5B/JARID1B的过表达与肝细胞癌的不良预后相关。
Oncotarget. 2018 Sep 28;9(76):34320-34335. doi: 10.18632/oncotarget.26144.
8
Culture of haploid blastocysts in FGF4 favors the derivation of epiblast stem cells with a primed epigenetic and transcriptional landscape.在 FGF4 中培养单倍体囊胚有利于获得具有初始表观遗传和转录景观的内细胞团干细胞。
Sci Rep. 2018 Jul 17;8(1):10775. doi: 10.1038/s41598-018-29074-6.
9
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.上皮-间质转化、癌症干细胞与耐药性:机制联系及临床意义
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629. doi: 10.1038/nrclinonc.2017.44. Epub 2017 Apr 11.
10
SMYD5 regulates H4K20me3-marked heterochromatin to safeguard ES cell self-renewal and prevent spurious differentiation.SMYD5调节H4K20me3标记的异染色质以保障胚胎干细胞自我更新并防止异常分化。
Epigenetics Chromatin. 2017 Feb 23;10:8. doi: 10.1186/s13072-017-0115-7. eCollection 2017.

H3K4 去甲基化酶 KDM5B 调节癌细胞特性和表观遗传可塑性。

H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity.

机构信息

Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.

出版信息

Oncogene. 2022 May;41(21):2958-2972. doi: 10.1038/s41388-022-02311-z. Epub 2022 Apr 19.

DOI:10.1038/s41388-022-02311-z
PMID:35440714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9426628/
Abstract

The H3K4 demethylase KDM5B is overexpressed in multiple cancer types, and elevated expression levels of KDM5B is associated with decreased survival. However, the underlying mechanistic contribution of dysregulated expression of KDM5B and H3K4 demethylation in cancer is poorly understood. Our results show that loss of KDM5B in multiple types of cancer cells leads to increased proliferation and elevated expression of cancer stem cell markers. In addition, we observed enhanced tumor formation following KDM5B depletion in a subset of representative cancer cell lines. Our findings also support a role for KDM5B in regulating epigenetic plasticity, where loss of KDM5B in cancer cells with elevated KDM5B expression leads to alterations in activity of chromatin states, which facilitate activation or repression of alternative transcriptional programs. In addition, we define KDM5B-centric epigenetic and transcriptional patterns that support cancer cell plasticity, where KDM5B depleted cancer cells exhibit altered epigenetic and transcriptional profiles resembling a more primitive cellular state. This study also provides a resource for evaluating associations between alterations in epigenetic patterning upon depletion of KDM5B and gene expression in a diverse set of cancer cells.

摘要

H3K4 去甲基化酶 KDM5B 在多种癌症类型中过表达,并且 KDM5B 的高表达水平与存活率降低有关。然而,KDM5B 的表达失调和 H3K4 去甲基化在癌症中的潜在机制贡献还了解甚少。我们的结果表明,多种类型的癌细胞中 KDM5B 的缺失导致增殖增加和癌症干细胞标志物的表达升高。此外,我们观察到在一组代表性癌细胞系中 KDM5B 耗竭后肿瘤形成增强。我们的研究结果还支持 KDM5B 在调节表观遗传可塑性中的作用,在高表达 KDM5B 的癌细胞中 KDM5B 的缺失导致染色质状态活性的改变,从而促进替代转录程序的激活或抑制。此外,我们定义了以 KDM5B 为中心的表观遗传和转录模式,支持癌细胞可塑性,其中 KDM5B 耗尽的癌细胞表现出改变的表观遗传和转录特征,类似于更原始的细胞状态。这项研究还为评估在一组多样化的癌细胞中 KDM5B 耗竭后表观遗传模式的改变与基因表达之间的关联提供了资源。